Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 513 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cullinan Therapeutics, Inc.
Market Cap
$1.02B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.02B
Net Profit Margin
-321.81%
TTM Avg
-893.93%
3Y Avg
-810.32%
5Y Avg
-689.93%
Market Cap
$1.01B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.04B
Net Profit Margin
-493.26%
TTM Avg
-198.62%
3Y Avg
-139.13%
5Y Avg
-250.17%
Market Cap
$1.05B
Net Profit Margin
-0.44%
TTM Avg
-16.00%
3Y Avg
-4.01%
5Y Avg
0.78%
Market Cap
$1.05B
Net Profit Margin
-2.66%
TTM Avg
-7.26%
3Y Avg
-9.19%
5Y Avg
-9.19%
Market Cap
$1.06B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$988.93M
Net Profit Margin
-727.04%
TTM Avg
-1969.28%
3Y Avg
-984.64%
5Y Avg
-984.64%
Market Cap
$954.32M
Net Profit Margin
-384.30%
TTM Avg
-367.92%
3Y Avg
-183.96%
5Y Avg
-122.64%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | $1.02B | 0.00% | 0.00% | 0.00% | 0.00% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | -321.81% | -893.93% | -810.32% | -689.93% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.01B | 0.00% | 0.00% | 0.00% | 0.00% |
| Immatics N.V. (IMTX)vs › | $1.04B | -493.26% | -198.62% | -139.13% | -250.17% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.05B | -0.44% | -16.00% | -4.01% | 0.78% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.05B | -2.66% | -7.26% | -9.19% | -9.19% |
| Teladoc Health, Inc. (TDOC)vs › | $1.06B | -7.13% | -23.45% | -155.72% | -114.72% |
| Aktis Oncology, Inc. (AKTS)vs › | $988.93M | -727.04% | -1969.28% | -984.64% | -984.64% |
| Kura Oncology, Inc. (KURA)vs › | $954.32M | -384.30% | -367.92% | -183.96% | -122.64% |
| CeriBell, Inc. (CBLL)vs › | $949.71M | -64.73% | -60.89% | -82.58% | -82.58% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | -0.37% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
